Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2022 07:30 ET | Source: Arbutus Biopharma Corporation

Arbutus Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Financially strong with a projected cash runway into the second quarter of 2024 HBsAg and HBV DNA remain at low levels with no evidence of clinical relapse up to 44 weeks after...
October 26, 2022 07:30 ET | Source: Arbutus Biopharma Corporation

Arbutus to Report Third Quarter 2022 Financial Results and Provide Corporate Update

WARMINSTER, Pa., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...